Stay updated on Fasinumab Long-Term Safety in OA Clinical Trial
Sign up to get notified when there's something new on the Fasinumab Long-Term Safety in OA Clinical Trial page.

Latest updates to the Fasinumab Long-Term Safety in OA Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedLocations now lists many new sites across the U.S. and internationally (Alabama, Arizona, Arkansas, California, Colorado, Florida, Georgia, Illinois, Kansas, Maryland, Massachusetts, Minnesota, Missouri, Nebraska, Nevada, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, South Carolina, Texas, Saxony, Baja California, Jalisco, Mexico City, Morelos, Sinaloa, Yucatán, Gauteng, Skåne County). The previous list of locations has been replaced.SummaryDifference1%

- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 was removed as a minor site/version update with no impact on core content or study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check49 days agoChange DetectedRevision: v3.3.1 was added and Revision: v3.2.0 was removed. This appears to reflect a software version update displayed on the page rather than changes to the study content.SummaryDifference0.0%

- Check57 days agoChange DetectedRemoved the site-wide notice about a lapse in government funding and potential updates to operating status; this change does not affect the study details or their presentation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check71 days agoChange DetectedThe Study Details page content and layout appear unchanged between the two screenshots. No new sections or items are evident; the overall structure remains the same.SummaryDifference0.2%

- Check100 days agoChange DetectedThe page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference2%

Stay in the know with updates to Fasinumab Long-Term Safety in OA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fasinumab Long-Term Safety in OA Clinical Trial page.